|
Press Releases |
|
|
|
Wednesday, September 8, 2021 |
|
阿诺医药宣布AN2025、AN0025与atezolizumab三联治疗晚期实体瘤1a期临床在美国完成首例患者给药 |
阿诺医药,一家专注于肿瘤治疗领域的创新型全球生物制药公司,今日宣布其口服泛PI3K抑制剂buparlisib(AN2025)、口服EP4拮抗剂(AN0025)与PD-L1抑制剂atezolizumab(阿替利珠单抗)三联疗法在晚期/转移性实体瘤患者中开展的Ia期临床试验已于美国成功完成首例患者给药。 more info >> |
|
阿諾醫藥宣佈AN2025、AN0025與atezolizumab三聯治療晚期實體瘤1a期臨床在美國完成首例患者給藥 |
阿諾醫藥,一家專注於腫瘤治療領域的創新型全球生物製藥公司,今日宣佈其口服泛PI3K抑制劑buparlisib(AN2025)、口服EP4拮抗劑(AN0025)與PD-L1抑制劑atezolizumab(阿替利珠單抗)三聯療法在晚期/轉移性實體瘤患者中開展的Ia期臨床試驗已于美國成功完成首例患者給藥。 more info >> |
|
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors |
Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been dosed in the Phase Ia clinical trial in the U.S. to evaluate the triple combination of AN2025 (buparlisib, oral pan-PI3K inhibitor), AN0025 (oral EP4 antagonist) and atezolizumab (PD-L1 inhibitor) in patients with locally advanced/metastatic tumors. more info >> |
|
Thursday, July 15, 2021 |
|
Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures |
Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
GAMELIGHT はJOYCITYのために日本と韓国で257%、英国で230%のROAS D7からD30成長を達成ーケーススタディ
Apr 30, 2024 10:00: JST
|
|
|
Rockbird media Presents Retail & E-commerce Summit Asia 2024 - 'Retail Revolution: Setting the Landscape Ablaze' in Manila
Apr 30, 2024 09:07 HKT/SGT
|
|
|
Hong Kong International Licensing Show creates cross-industry business opportunities
Apr 29, 2024 23:00 HKT/SGT
|
|
|
CITIC Telecom CPC Garners Multiple Ecosystem Partners Awards Reinforces Collaborative Capabilities, Drives Breakthrough Innovation & Shares Sustainable Development Results
Apr 29, 2024 22:00 HKT/SGT
|
|
|
FTLife Pre-Announces Name Change to Chow Tai Fook Life Insurance Company Limited
Apr 29, 2024 21:47: JST
|
|
|
富通保险宣布将更名为周大福人寿保险有限公司
Apr 29, 2024 21:04 HKT/SGT
|
|
|
富通保險宣佈將更名為周大福人壽保險有限公司
Apr 29, 2024 20:57 HKT/SGT
|
|
|
FTLife Pre-Announces Name Change to Chow Tai Fook Life Insurance Company Limited
Apr 29, 2024 20:47 HKT/SGT
|
|
|
INNIO Group's 2023 Sustainability Report: Progress in Implementing Corporate Sustainability Goals
Apr 29, 2024 20:39 HKT/SGT
|
|
|
Q&M Dental Enhances its Digital Capabilities by Integrating Align Technology's Newest iTero Lumina(TM) Intraoral Scanner Across Dental Clinics in Singapore
Apr 29, 2024 19:00 HKT/SGT
|
|
|
「香港智营设计大赏2024」公布得奖名单
Apr 29, 2024 19:00 HKT/SGT
|
|
|
「香港智營設計大賞2024」公佈得獎名單
Apr 29, 2024 19:00 HKT/SGT
|
|
|
SPARX Group Establishes Space Frontiers Second Fund
Apr 29, 2024 18:49 JST
|
|
|
Rockbird media Presents HR Leaders & HR Tech Strategy Meeting 2024: 'Rehumanizing Work with Emerging Technologies' in Manila
Apr 29, 2024 17:28 HKT/SGT
|
|
|
MHI Establishes Local Subsidiary "Mitsubishi Heavy Industries Vietnam"
Apr 29, 2024 18:00 JST
|
|
|
|
More News >> |
|
|
|
|
|